H. Heijink (Groningen, Netherlands), A. Faiz (Ultimo (NSW), Australia)
Introduction
|  |
LSC - 2022 - A high probability of short-range interactions between fibrocytes and CD8+ T cells potentiates the inflammatory response in COPD
E. Eyraud (Bordeaux, France), E. Maurat (Bordeaux, France), P. Vallois (Vandoeuvre-lès-Nancy, France), J. Sac-Epée (Vandoeuvre-lès-Nancy, France), P. Henrot (Bordeaux, France), M. Zysman (Bordeaux, France), L. Florian (Bordeaux, France), J. Sibarita (Bordeaux, France), H. Bégueret (Bordeaux, France), P. Girodet (Bordeaux, France), T. Matthieu (Bordeaux, France), R. Hustache-Castaing (Bordeaux, France), C. Contin-Bordes (Bordeaux, France), P. Berger (Bordeaux, France), I. Dupin (Bordeaux, France)
|  |
LSC - 2022 - The potential role of innate lymphoid cells in non-allergic neutrophilic asthma model
A. Jonckheere (Leuven, Belgium), B. Steelant (Leuven, Belgium), S. Seys (Leuven, Belgium), T. Decaesteker (Leuven, Belgium), J. Cremer (Leuven, Belgium), E. Dilissen (Leuven, Belgium), D. Schols (Leuven, Belgium), Y. Iwakura (Chiba, Japan), J. Vanoirbeek (Leuven, Belgium), L. Dupont (Leuven, Belgium), D. Bullens (Leuven, Belgium)
|   |
Altered Site-Specific Expression Patterns of Interleukin-33 and its Receptor ST2 in COPD Lungs
C. Sanden (Lund, Sweden), P. Siddhuraj (Lund, Sweden), J. Jönsson (Lund, Sweden), C. Lindö (Lund, Sweden), J. Nys (Cambridge, United Kingdom), D. Schofield (Cambridge, United Kingdom), I. Scott (Cambridge, United Kingdom), S. Lindstedt (Lund, Sweden), R. Kolbeck (Gaithersburg, United States), A. Humbles (Cambridge, United Kingdom), R. Lutter (Amsterdam, Netherlands), S. Cohen (Cambridge, United Kingdom), J. Erjefalt (Lund, Sweden)
| |
Airway myeloperoxidase (MPO) is associated with increased risk of exacerbations in COPD
S. Rosengren (Gothenburg, Sweden), S. Tångefjord (Gothenburg, Sweden), G. De Palo (Gothenburg, Sweden), J. Horndahl (Gothenburg, Sweden), M. Ingelsten (Gothenburg, Sweden), A. Gilmour (Dundee, United Kingdom), M. Long (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), K. Ostridge (Gothenburg, Sweden), J. Chalmers (Dundee, United Kingdom)
| |
Oxidised IL-33 signals via RAGE/EGFR to drive a COPD-associated phenotype
S. Strickson (Cambridge, United Kingdom), K. Houslay (Cambridge, United Kingdom), V. Negri (Cambridge, United Kingdom), Y. Ohne (Gaithersburg, United States), T. Ottosson (Gothenburg, Sweden), R. Dodd (Cambridge, United Kingdom), C. Chaillan Huntington (Cambridge, United Kingdom), J. Li (Cambridge, United Kingdom), H. Killick (Cambridge, United Kingdom), D. Rees (Cambridge, United Kingdom), S. Koch (Cambridge, United Kingdom), G. Sims (Gaithersburg, United States), I. Scott (Cambridge, United Kingdom), X. Romero Ros (Cambridge, United Kingdom), E. Cohen (Cambridge, United Kingdom)
| |
IL-13 modulates exosome production and miRNAs cargo in bronchial epithelial cells in severe asthma
M. Klein (Québec, Canada), P. Gagnon (Québec, Canada), M. Salem (Québec, Canada), M. Rouabhia (Québec, Canada), J. Chakir (Québec, Canada)
| |
Profiling small extracellular vesicles (EVs) in idiopathic pulmonary fibrosis (IPF)
S. Asghar (Cambridge, United Kingdom), S. Monkley (Cambridge, United Kingdom), L. Murray (Cambridge, United Kingdom), C. Overed-Sayer (Cambridge, United Kingdom), P. Molyneaux (London, United Kingdom)
| |
Airway epithelial gene expression is altered in survivors of preterm birth
D. Evans (Nedlands, Australia), J. Hillas (Nedlands, Australia), T. Iosifidis (Nedlands, Australia), S. Simpson (Nedlands, Australia), A. Kicic (Nedlands, Australia), P. Agudelo-Romero (Nedlands, Australia)
| |
Late Breaking Abstract - Beyond barrier function – claudin-1 as a therapeutic target candidate for idiopathic pulmonary fibrosis
J. Ruwisch (Hannover, Germany), B. Jäger (Hannover, Germany), O. Terwolbeck (Hannover, Germany), G. Teixeira (Basel, Switzerland), F. Juehling (Strasbourg, France), T. Baumert (Strasbourg, France), A. Prasse (Hannover, Germany)
| |